Skip to content

Clinical trials

Phase 2 Dwarfism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20141
20161
20181
20191
20203
20211
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical5
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
QED Therapeutics, a BridgeBio company3
Andrew Dauber1
Ascendis Pharma A/S1
Nemours Children's Clinic1
Pfizer1
Roopa Kanakatti Shankar, MBBS, MS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism16
Bone Diseases9
Achondroplasia8
Musculoskeletal Diseases7
Osteochondrodysplasias5
Bone Diseases, Developmental4
Genetic Diseases, Inborn4
Mucopolysaccharidosis IV4
Growth Disorders3
Noonan Syndrome2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.